← Leaderboards
Elizabeth Berger
Wayne State University
$4,618,652
Attributed
$4,618,652
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,618,652 · 4
By mechanism
R01$4,618,652 · 4
Top collaborators
No co-investigators on record.
Most similar at Wayne State University
Same institution · by research overlap
- Rafael A. Fridman$9,123,443
- Linda D Hazlett$19,065,465
- Shunbin Xu$3,294,824
- Patrick Shean-Young Lee$183,256
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponsePathogenesisCellsBlindnessInflammationRestorationDisease OutcomeCorneaResearch DesignAntibioticsKeratitisPseudomonas AeruginosaClinical ApplicationVisualPre-ClinicalImmuneInflammatoryImmune ResponsePathogenResolutionInfectionAntibiotic TherapyEye InfectionsAntibiotic Resistance
Grant awards (11)
Restoration of Structure and Function in the Diabetic Cornea$615,979
R01 · FY2025 · EY · contact PI
The Role of Eosinophils in Modulating the Corneal Response to Infection$586,258
R01 · FY2025 · EY · contact PI
Thymosin beta-4 as an Adjunct Treatment for Bacterial Keratitis$385,000
R01 · FY2023 · EY · contact PI
Thymosin beta-4 as an Adjunct Treatment for Bacterial Keratitis$373,448
R01 · FY2022 · EY · contact PI
Thymosin beta-4 as an Adjunct Treatment for Bacterial Keratitis$373,451
R01 · FY2021 · EY · contact PI
Thymosin beta-4 as an Adjunct Treatment for Bacterial Keratitis$385,000
R01 · FY2020 · EY · contact PI
Thymosin beta-4 as an Adjunct Treatment for Bacterial Keratitis$385,000
R01 · FY2019 · EY · contact PI
VIP and Disease Resolution of Bacterial-Induced Ocular Infection$380,450
R01 · FY2017 · EY · contact PI
VIP and Disease Resolution of Bacterial-Induced Ocular Infection$380,450
R01 · FY2016 · EY · contact PI
VIP and Disease Resolution of Bacterial-Induced Ocular Infection$378,367
R01 · FY2015 · EY · contact PI
VIP and Disease Resolution of Bacterial-Induced Ocular Infection$375,249
R01 · FY2014 · EY · contact PI